Advisory Board

  • Medical Physics

Prof. Dr. Hanne Kooy, PhD

Prof. Kooy is the Director of Physics at the Francis H. Burr Proton Therapy Center at the Massachusetts General Hospital in Boston, and an Associate Professor of Radiation Therapy at HarvardMedicalSchool. During the last 15 years, Prof. Kooy has led the medical physics development in proton therapy at the center and has become a well recognized scientific figure in the field. His recent  book “Proton and Charged Particle Radiotherapy”, written with Tomas F. DeLaney, MD, is a reference textbook for radiotherapy specialists. The F. H. Burr Proton Therapy Center continues the clinical program that commenced at the Harvard Cyclotron Lab in the late ‘60’s where Robert Wilson conceptualized the clinical use of protons in 1947.

 

  • Oncology

Prof. Dr. Zelig A. Tochner, MD

Dr. Tochner is the Clinical Director of Proton Therapy Project at University of Pennsylvania. Opening in 2010,  The Roberts Proton Therapy Center has integrated the most advanced technological developments. Dr. Tochner was one of the leading specialists who determined the clinical and technological needs of the center. In addition, Dr. Tochner is a Clinical Director of University of Pennsylvania’s Department of Radiation Oncology and currently serves as Chief of Neuro-Oncology and Pediatric Radiation Oncology Department. Prior to this, Dr. Tochner held several senior positions at the NCI’s Radiation Oncology Branch and at Hadassah University Hospital in Jerusalem, where he served as the Head of the Oncology Department. Dr. Tochner joined P-CURE when the enterprise was first launched.


Dr. Raphael Pfeffer, MD

Dr. Pfeffer is the Chief of the Radiation Oncology Department at the Chaim Sheba Medical Center in Israel. Like Dr. Tochner, he joined P-CURE right at the beginning and since then he has been acting as a leading clinical consultant. Dr. Pfeffer is a world-renowned specialist in the field of radiation therapy and a talented scientist. His knowledge, experience and scientific creativity allow the company to formulate the best clinically valuable solutions for both oncologists and patients. Dr. Pfeffer completed his medical studies at the University College Hospital Medical School in London and a combined Clinical and Research Fellowship at the HarvardJointCenter for Radiotherapy. Dr. Pfeffer participates in clinical studies with the European Organization for Research and Treatment of Cancer Radiotherapy Group.


Prof. Dr. Gidi Rechavi, MD, PhD

Prof. Rechavi is the Head of Pediatric Oncology Department at the Chaim Sheba Medical Center in Israel. He is a world-renowned specialist in the field and remarkably combines his clinical, management, and scientific activities. As a result he had more than 300 publications in the most respectable scientific journals; and he leads the cancer research laboratory in the Hospital; he is involved in many clinical studies; he is the Head of the Chaim Sheba Cancer Center. He joined the company in the very beginning. He brings to the company his scientific and clinical opinion on the product development, particularly on the product applications for the treatment of children.

 

  • Reimbursement and Marketing

Mr. Stephen Jacobs

Stephen Jacobs has played a critical role in the clinical development of proton therapy. Experienced in governmental affairs, marketing and public relations, he helped plan the first proton site at Loma Linda University Medical Center and the technology transfer from Department of Energy Fermi National Accelerator Lab. For over 23 years, he has led the campaign to significantly fund proton therapy reach and development through Congressional appropriations and governmental support. Mr. Jacobs is a founding Board member of the National Association of Proton Therapy, and an active participant in the Proton Consortium. He is former Assistant Secretary of the Department of Energy, and a strategic planner for the President Reagan’s White House. He holds a B.S. degree from the University of Maryland, and an M.A. from The American University.